MFS Emerging Markets Debt Fund Class R2 (MEDEX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
12.98
+0.02 (0.15%)
At close: Feb 13, 2026
Fund Assets7.58B
Expense Ratio1.31%
Min. Investment$0.00
Turnover69.00%
Dividend (ttm)0.60
Dividend Yield4.64%
Dividend Growth-21.04%
Payout FrequencyMonthly
Ex-Dividend Daten/a
Previous Close12.96
YTD Return1.82%
1-Year Return13.09%
5-Year Return10.50%
52-Week Low11.17
52-Week High12.98
Beta (5Y)n/a
Holdings557
Inception DateDec 1, 2008

About MEDEX

The MFS Emerging Markets Debt Fund Class R2 is a mutual fund that seeks to deliver a total return with a primary emphasis on high current income, while also considering long-term capital appreciation. This fund invests predominantly in a diversified portfolio of debt securities issued by sovereign and corporate entities in emerging market countries, with a focus on both U.S. dollar and local currency denominated bonds. Its investment process is notably research-driven, emphasizing active country and security selection alongside disciplined risk management and downside protection. The fund further manages volatility through broad diversification and maintaining liquid holdings. The fund is benchmarked against the JPMorgan Emerging Markets Bond Index Global, reflecting its aim to capture opportunities and manage risks across a wide array of developing markets. As of May 2025, the portfolio held hundreds of issues across nearly 180 issuers, demonstrating significant breadth and diversification. The management team brings substantial continuity and experience, having steered the fund through multiple market cycles since inception. The fund plays a key role in providing access to emerging market fixed income opportunities, contributing to global portfolio diversification and offering exposure to dynamic economies outside the developed markets.

Fund Family MFS
Category Emerging Markets Bond
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol MEDEX
Share Class R2
Index JP Morgan EMBI Global Diversified TR

Performance

MEDEX had a total return of 13.09% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.70%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

SymbolProviderNameExpense Ratio
FGYMXFidelityFidelity Advisor New Markets Income Fund - Class C0.76%
FGWMXFidelityFidelity Advisor New Markets Income Fund - Class M0.76%
FGBMXFidelityFidelity Advisor New Markets Income Fund - Class Z0.76%
FGZMXFidelityFidelity Advisor New Markets Income Fund - Class I0.76%
FNMIXFidelityFidelity New Markets Income Fund0.76%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
MEDHXR60.70%
MEDIXI0.81%
MEDGXR40.81%
MEDAXA1.06%

Dividend History

Ex-DividendAmountPay Date
Jan 30, 2026$0.05258Feb 2, 2026
Dec 31, 2025$0.05262Dec 31, 2025
Nov 28, 2025$0.0526Dec 1, 2025
Oct 31, 2025$0.05263Nov 3, 2025
Sep 30, 2025$0.0527Oct 1, 2025
Aug 29, 2025$0.0513Sep 2, 2025
Full Dividend History